On November 28, 2022, Professor Li Jicheng, Chairman of the Chinese Society of Precision Medicine (Preparatory), Chairman of the Translational Medicine Branch of the Chinese Pharmaceutical Biotechnology Association, and Chairman of the Zhejiang Translational Medicine Society, visited GENOM BIO for guidance and inspection. Dr. Li Liang, Chairman and President of Zhejiang GENOM Life and Health Holding Group, Vice President Wang Xichen, Vice President Guo Yonglin, General Manager of the Big Health Division Zhong Ao and other company leaders accompanied the inspection.
Dr. Li Liang, Chairman and CEO of GENOM Biotechnology, introduced the company's basic situation, development history, technical research and development team, main product business, etc. to Professor Li Jicheng. After listening to the introduction, Professor Li Jicheng affirmed the comprehensive development of GENOM BIO, fully affirmed its layout planning in the cell industry, and its innovative research and development spirit, and hoped to persist in innovation, continue to shine in the cell industry, and become bigger and stronger.
Talking about the future of the cell industry, Professor Li Jicheng said that it has a broad application market and a relatively deep scientific research accumulation, and it also has the support of favorable policies continuously issued by the state and local governments. The development momentum is strong, and such a good environment also requires the continuous efforts of enterprises to increase research and development efforts, break through the core technology of cell production, and create an advanced automated and industrialized cell production process system, which is a key step to the healthy development of the cell industry. In the future, GENOM BIO will also follow the momentum of the development of the cell industry, give full play to the spirit of innovation, carry out in-depth cell-related research, strengthen in-depth cooperation with Zhejiang University, Zhejiang Provincial People's Hospital and other universities and hospitals, build a cell industry ecological chain, promote the steady development and transformation of cell industry projects, and promote the healthy and benign development of the cell industry.